STVN (Stevanato) יחס שווי שוק לשווי בספרים

Stevanato Group S.p.A. (STVN) generates revenue by producing high-tech pharmaceutical packaging, supplying glass vials and syringes for diabetes medications. This price trend chart illustrates the asset's performance, with its metric currently at 3.02. Manufacturing capacities across Asia, Europe, and the US ensure the sterility of biologics, while deep integration into the supply chains of industry behemoths creates a powerful moat against competition.

This indicator measures the market revaluation of net assets, determining the premium investors are willing to pay for the business's intangible advantages relative to its book value. By analyzing the market-to-book premium ratio for Stevanato Group S.p.A. (STVN), one can assess the company's resilience within a high-tech oligopoly, where dominance in the sterile packaging segment justifies a high cost of capital but increases the risk of a correction.